IRadimed IRMD 深 沪
等待开盘 10-03 09:30:00 美东时间
85.40
+0.100
+0.12%
华盛通- 最 高86.27
- 今 开86.14
- 成交量 11.95万股
- 最 低 84.525
- 昨 收 85.30
- 总市值 10.92亿
- 52周最高 107.30
- 市盈率 静 48.83
- 换手率 0.93%
- 52周最低 70.07
- 委 比 11.02%
- 总股本 1278.70万
- 历史最高 107.30
- 量 比 0.73
- 振 幅 2.05%
- 历史最低 1.35
- 每 手 1
- 风险率 7.91%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Needham Initiates Coverage On iRadimed with Hold Rating
Needham analyst David Saxon initiates coverage on iRadimed (NASDAQ:IRMD) with a Hold rating.
09-22 19:04
IRadimed Corp Earnings Call Highlights Ramp, Resilience
Iradimed Corp (($IRMD)) has held its Q2 earnings call. Read on for the main hig...
08-05 08:58
iRadimed declares $0.20 dividend
iRadimed (IRMD) declares $0.20/share quarterly dividend, in line with previous. Forward yield 0.88% Payable Aug. 28; for shareholders of record Aug. 14; ex-div Aug. 14. See IRMD Dividend Scorecard, Yi...
08-03 12:37
iRadimed Sees Q3 Adj EPS $0.54-$0.59 vs $0.52 Est; Sees Sales $23.000M-$24.500M vs $23.650M Est
iRadimed (NASDAQ:IRMD) is looking for Q3 Adj EPS of $0.54-$0.59 vs $0.52 analyst estimate. sees sales of $23.000 million-$24.500 million vs $23.650 million analyst estimate.
07-31 20:17
iRadimed Affirms FY2026 GAAP EPS Guidance of $1.90-$2.05 vs $1.91 Est
iRadimed (NASDAQ:IRMD) affirms FY2026 GAAP EPS guidance from $1.90-$2.05 to $1.90-$2.05 vs $1.91 analyst estimate..
07-31 20:16
iRadimed Raises FY2026 Adj EPS Guidance from $2.06-$2.21 to $2.09-$2.24 vs $2.08 Est; Raises FY2026 Sales Guidance from $91.000M-$96.000M to $91.000B-$96.000B vs $91.300M Est
iRadimed (NASDAQ:IRMD) raises FY2026 Adj EPS guidance from $2.06-$2.21 to $2.09-$2.24 vs $2.08 analyst estimate. Raises FY2026 sales outlook from $91.000 million-$96.000 million to $91.000 billion-$96.000 billion vs $91.300 million estimate.
07-31 20:16
iRadimed Sees Q3 GAAP EPS $0.49-$0.54 vs $0.49 Est
iRadimed (NASDAQ:IRMD) is looking for Q3 GAAP EPS of $0.49-$0.54 vs $0.49 analyst estimate..
07-31 20:16
iRadimed Sees Q2 GAAP EPS $0.40-$0.44 vs $0.42 Est
iRadimed (NASDAQ:IRMD) is looking for Q2 GAAP EPS of $0.40-$0.44 vs $0.42 analyst estimate..
05-01 20:33
iRadimed Q1 Adj. EPS $0.49 Beats $0.45 Estimate, Sales $21.979M Beat $21.315M Estimate
iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.49 per share which beat the analyst consensus estimate of $0.45 by 8.89 percent. This is a 16.67 percent increase over earnings of $0.42 per share from the same
05-01 20:31
Earnings Scheduled For May 1, 2026
Companies Reporting Before The Bell • WisdomTree (NYSE:WT) is projected to repo...
05-01 19:11
